RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma

Adjuvant transcatheter arterial chemoembolization (TACE) protects against hepatocellular carcinoma (HCC) and is associated with reduced disease recurrence and improved outcome after surgery. However, deterioration of liver function after TACE negatively impacts the patient prognosis and limits it us...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Zhang, Jian, Jiang, Tian-Yi, Jiang, Bei-Ge, Yang, Chun, Tan, Ye-Xiong, Yang, Ning, Pan, Yu-Fei, Ding, Zhi-Wen, Yang, Guang-Zhen, Wu, Meng-Chao, Dong, Li-Wei, Wang, Hong-Yang
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413664/
https://ncbi.nlm.nih.gov/pubmed/25605019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars